scispace - formally typeset
Open AccessJournal ArticleDOI

The past, present and future of anti-malarial medicines

Reads0
Chats0
TLDR
The range of anti-malarial medicines developed over the years are reviewed, beginning with the discovery of quinine in the early 1800s, through to modern day ACT and the recently-approved tafenoquine.
Abstract
Great progress has been made in recent years to reduce the high level of suffering caused by malaria worldwide. Notably, the use of insecticide-treated mosquito nets for malaria prevention and the use of artemisinin-based combination therapy (ACT) for malaria treatment have made a significant impact. Nevertheless, the development of resistance to the past and present anti-malarial drugs highlights the need for continued research to stay one step ahead. New drugs are needed, particularly those with new mechanisms of action. Here the range of anti-malarial medicines developed over the years are reviewed, beginning with the discovery of quinine in the early 1800s, through to modern day ACT and the recently-approved tafenoquine. A number of new potential anti-malarial drugs currently in development are outlined, along with a description of the hit to lead campaign from which it originated. Finally, promising novel mechanisms of action for these and future anti-malarial medicines are outlined.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.

Rob W. van der Pluijm, +102 more
- 11 Mar 2020 - 
TL;DR: Triple artemisinin-based combination therapies (TACTs), which combine existing co-formulated ACTs with a second partner drug that is slowly eliminated, might provide effective treatment and delay emergence of antimalarial drug resistance.
Journal ArticleDOI

The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY.

TL;DR: The IUPHAR/BPS Guide to PHARMACOLOGY is an open-access, expert-curated database of molecular interactions between ligands and their targets that provides new pharmacological content, including molecular targets in the malaria parasite, interaction data for ligands with antimalarial activity, and establishes curation of data from screening assays.
Journal ArticleDOI

Triple Artemisinin-Based Combination Therapies for Malaria – A New Paradigm?

TL;DR: Triple artemisinin-based combination therapies will provide one of the last remaining safe and effective treatments for falciparum malaria that can be deployed rapidly in the Greater Mekong Subregion, whereas their deployment beyond the GMS could delay or prevent the global emergence and spread of resistance to currently available drugs.
Journal ArticleDOI

Artemisia annua, a Traditional Plant Brought to Light

TL;DR: The purpose of this review is to gather and describe the data concerning the main chemical components produced by Artemisia annua and to describe the state of the art about the biological activities reported for this plant and its compounds beyond malaria.
References
More filters
Journal ArticleDOI

Evidence of Artemisinin-Resistant Malaria in Western Cambodia

TL;DR: Artemisinins are potent and rapidly acting antimalarial drugs, and their widespread use for treating patients with Plasmodium falciparum malaria raises the question of emerging drug resistance.
Journal ArticleDOI

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria

TL;DR: In pregnancy, quinine continues to play a critical role in the management of malaria, especially in the first trimester, and it will remain a mainstay of treatment until safer alternatives become available.
Related Papers (5)

Spread of Artemisinin Resistance in Plasmodium falciparum Malaria

Elizabeth A. Ashley, +82 more